R. A. Ach, H. Wang, and B. Curry, Measuring microRNAs: comparisons of microarray and quantitative PCR measurements, and of different total RNA prep methods, BMC Biotechnol, vol.8, p.69, 2008.

V. Bihrer, O. Waidmann, M. Friedrich-rust, N. Forestier, S. Susser et al., Serum MicroRNA-21 as marker for necroinflammation in Hepatitis C patients with and without hepatocellular carcinoma, PLoS One, vol.6, 2011.

S. A. Bustin, V. Benes, J. Garson, J. Hellemans, J. Huggett et al., Nat. Methods, vol.10, 2013.

V. J. Cookson, M. A. Bentley, B. V. Hogan, K. Horgan, B. E. Hayward et al., Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumours, Cell. Oncol. (Dordr.), vol.35, pp.301-308, 2012.

M. A. Cortez, C. Bueso-ramos, J. Ferdin, G. Lopez-berestein, A. K. Sood et al., MicroRNAs in body fluidsdthe mix of hormones and biomarkers, Nat. Rev. Clin. Oncol, vol.8, pp.467-477, 2011.

C. M. Croce, Causes and consequences of microRNA dysregulation in cancer, Nat. Rev. Genet, vol.10, 2009.

G. A. Ganepola, J. R. Rutledge, P. Suman, A. Yiengpruksawan, and D. H. Chang, Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer, World J. Gastrointest. Oncol, vol.6, 2014.

A. J. Gillis, M. A. Rijlaarsdam, R. Eini, L. C. Dorssers, K. Biermann et al., Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principle, Mol. Oncol, vol.7, 2013.

A. R. Gruber, R. Lorenz, S. H. Bernhart, R. Neub?-ock, and I. L. Hofacker, The Vienna RNA websuite, Nucleic Acids Res, vol.36, 2008.

M. Ha and V. N. Kim, Regulation of microRNA biogenesis, Nat. Rev. Mol. Cell Biol, vol.15, 2014.

J. Jarry, D. Schadendorf, C. Greenwood, A. Spatz, and L. C. Van-kempen, The validity of circulating microRNAs in oncology: five years of challenges and contradictions, Mol. Oncol, vol.8, 2014.

Y. Kim, J. Yeo, B. Kim, M. Ha, and V. N. Kim, Short structured RNAs with low GC content are selectively lost during extraction from a small number of cells, Mol. Cell, vol.46, 2012.

M. B. Kirschner, S. C. Kao, J. J. Edelman, N. J. Armstrong, M. P. Vallely et al., Haemolysis during sample preparation alters microRNA content of plasma, PLoS One, vol.6, 2011.

A. M. Liu, T. Yao, W. Wang, K. Wong, N. P. Lee et al., Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study, BMJ Open, vol.2, 2012.

J. S. Mcdonald, D. Milosevic, H. V. Reddi, S. K. Grebe, and A. Algecirasschimnich, Analysis of circulating microRNA: preanalytical and analytical challenges, Clin. Chem, vol.57, 2011.

X. Meng, S. A. Joosse, V. M?-uller, F. Trillsch, K. Milde-langosch et al., Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients, Br. J. Cancer, vol.113, 2015.

P. Mestdagh, N. Hartmann, L. Baeriswyl, D. Andreasen, N. Bernard et al., Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study, Nat. Methods, vol.11, 2014.

P. S. Mitchell, R. K. Parkin, E. M. Kroh, B. R. Fritz, S. K. Wyman et al., Circulating microRNAs as stable blood-based markers for cancer detection, Proc. Natl. Acad. Sci. U. S. A, vol.105, 2008.

L. Moldovan, K. E. Batte, J. Trgovcich, J. Wisler, C. B. Marsh et al., Methodological challenges in utilizing miRNAs as circulating biomarkers, J. Cell. Mol. Med, vol.18, 2014.

M. Monleau, S. Bonnel, T. Gostan, D. Blanchard, V. Courgnaud et al., Comparison of different extraction techniques to profile microRNAs from human sera and peripheral blood mononuclear cells, BMC Genomics, vol.15, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02191582

V. M?-uller, S. Gade, B. Steinbach, S. Loibl, G. Von-minckwitz et al., Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial, Breast Cancer Res. Treat, vol.147, pp.61-68, 2014.

S. Pradervand, J. Weber, F. Lemoine, F. Consales, A. Paillusson et al.,

E. Beaudoing, O. Hagenb?-uchle, and K. Harshman, Concordance among digital gene expression, microarrays, and qPCR when measuring differential expression of microRNAs, BioTechniques, vol.48, 2010.

C. C. Pritchard, E. Kroh, B. Wood, J. D. Arroyo, K. J. Dougherty et al., Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies, Cancer Prev. Res. (Phila.), vol.5, pp.492-497, 2012.

K. E. Resnick, H. Alder, J. P. Hagan, D. L. Richardson, C. M. Croce et al., The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform, Nat. Rev. Clin. Oncol, vol.112, pp.1333-1342, 2009.

I. St?-uckrath, B. Rack, W. Janni, B. Pantel, K. Schwarzenbach et al., Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients, Oncotarget, vol.6, 2015.

G. W. Tan, A. S. Khoo, and L. P. Tan, Evaluation of extraction kits and RT-qPCR systems adapted to high-throughput platform for circulating miRNAs, Sci. Rep, vol.5, p.9430, 2015.

K. W. Witwer, Circulating microRNA biomarker studies: pitfalls and potential solutions, Clin. Chem, vol.61, 2015.

K. Wu, L. Li, and S. Li, Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated metaanalysis based on 36 studies, Tumour Biol. e J. Int. Soc. Oncodevelopmental Biol. Med, vol.36, 2015.